ReviewOncoTargets and therapy2019

Spotlight on aldoxorubicin (INNO-206) and its potential in the treatment of soft tissue sarcomas: evidence to date.

Lee D CranmerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.